Literature DB >> 18489947

Usefulness of cardiac magnetic resonance imaging combined with low-dose dobutamine stress to detect an abnormal ventricular stress response in children and young adults after fontan operation at young age.

Daniëlle Robbers-Visser1, Derk Jan Ten Harkel, Livia Kapusta, Jan L Strengers, Michiel Dalinghaus, Folkert J Meijboom, Peter M Pattynama, Ad J Bogers, Willem A Helbing.   

Abstract

After Fontan operation, patients are limited in increasing cardiac output and in exercise capacity. This has been related to impaired preload or other factors leading to decreased global ventricular performance with stress. To study these factors, the stress responses of functionally univentricular hearts were assessed at rest and during low-dose dobutamine stress using cardiovascular magnetic resonance imaging. Thirty-two patients after Fontan completion at young age were included (27 with total cavopulmonary connection, 5 with atriopulmonary connection; mean age 13.3 years, range 7.5 to 22.2; 23 male patients; median follow-up after Fontan operation 8.1 years, range 5.2 to 17.8). A multiphase short-axis stack of 10 to 12 contiguous slices of the systemic ventricle was obtained at rest and during low-dose dobutamine stress cardiovascular magnetic resonance imaging (maximum 7.5 microg/kg/min). With stress-testing, heart rate, ejection fraction, and cardiac index increased adequately (p <0.001). There was an abnormal decrease in end-diastolic volume and an adequate decrease in end-systolic volume (p <0.001). Stroke volume did not change with stress testing (p = 0.15). At rest, dominant left ventricles had higher ejection fractions than dominant right ventricles (p = 0.01), but this difference disappeared with stress testing. In conclusion, a functionally univentricular heart after Fontan completion at young age has an adequate increase in ejection fraction with beta-adrenergic stimulation. However, as a result of impaired preload with stress, cardiac output can be increased only by increasing heart rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18489947     DOI: 10.1016/j.amjcard.2008.01.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Update on the Role of Cardiac Magnetic Resonance Imaging in Congenital Heart Disease.

Authors:  Prabhakar Rajiah; Animesh Tandon; Gerald F Greil; Suhny Abbara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

Review 2.  Myocardial Viability on Cardiac Magnetic Resonance.

Authors:  Ana Luiza Mansur Souto; Rafael Mansur Souto; Isabella Cristina Resende Teixeira; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2017-05       Impact factor: 2.000

3.  Caval flow reflects Fontan hemodynamics: quantification by magnetic resonance imaging.

Authors:  S Ovroutski; S Nordmeyer; O Miera; P Ewert; K Klimes; T Kühne; F Berger
Journal:  Clin Res Cardiol       Date:  2011-11-18       Impact factor: 5.460

4.  Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.

Authors:  Jill M Gelow; Howard K Song; Joseph B Weiss; James O Mudd; Craig S Broberg
Journal:  J Heart Lung Transplant       Date:  2013-08-06       Impact factor: 10.247

5.  Respiratory Training Late After Fontan Intervention: Impact on Cardiorespiratory Performance.

Authors:  Lamia Ait Ali; Alessandro Pingitore; Paolo Piaggi; Fabio Brucini; Mirko Passera; Marco Marotta; Alessandra Cadoni; Claudio Passino; Giosuè Catapano; Pierluigi Festa
Journal:  Pediatr Cardiol       Date:  2018-01-19       Impact factor: 1.655

6.  Magnetic resonance imaging catheter stress haemodynamics post-Fontan in hypoplastic left heart syndrome.

Authors:  Kuberan Pushparajah; James K Wong; Hannah R Bellsham-Revell; Tarique Hussain; Israel Valverde; Aaron Bell; Aphrodite Tzifa; Gerald Greil; John M Simpson; Shelby Kutty; Reza Razavi
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-07-18       Impact factor: 6.875

7.  What Limits Cardiac Performance during Exercise in Normal Subjects and in Healthy Fontan Patients?

Authors:  André La Gerche; Marc Gewillig
Journal:  Int J Pediatr       Date:  2010-09-07

8.  Exercise testing and prescription in patients with congenital heart disease.

Authors:  A D J Ten Harkel; T Takken
Journal:  Int J Pediatr       Date:  2010-09-06

Review 9.  Impairments in Pulmonary Function in Fontan Patients: Their Causes and Consequences.

Authors:  Karina Laohachai; Julian Ayer
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.418

10.  Long-Term Serial Follow-Up of Pulmonary Artery Size and Wall Shear Stress in Fontan Patients.

Authors:  Sjoerd S M Bossers; Merih Cibis; Livia Kapusta; Wouter V Potters; Miranda M Snoeren; Jolanda J Wentzel; Adriaan Moelker; Willem A Helbing
Journal:  Pediatr Cardiol       Date:  2016-01-12       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.